Thomas A. Gallo, MS, MDA, is executive director of the Virginia Cancer Institute in Richmond, Virginia. In this role, he manages all aspects of a 24-provider medical oncology practice with 7 medical offices, ambulatory infusion centers, laboratories, and more than 200 employees. Among his responsibilities are strategic planning, operations, financial management, personnel management, and purchasing.
Mr. Gallo has been an active member of the Association of Community Cancer Centers (ACCC) for more than 10 years. He served as ACCC President-Elect 2017-2018. Currently, he also serves on ACCC’s Governmental Affairs Committee, which he previously chaired. He has presented at a number of ACCC Annual Meetings and has previously served on the ACCC Board of Trustees (2004-2005).
In addition to his involvement with ACCC, Mr. Gallo is a member of the Board of Directors of MD Value Care, an ACO of independent physician practices; past president of the Executive Committee of the MGMA Administrators in Oncology-Hematology Assembly (AOHA); a current member and former president of the Board of Directors of the Virginia Association of Hematologists and Oncologists (VAHO); and a former board member of the Community Oncology Alliance.
Prior to entering the healthcare field, Mr. Gallo was a commercial banker with Marine Midland Bank in New York City and Central Fidelity Bank in Richmond, Virginia.
He received a BA in Economics from the College of William and Mary in Williamsburg, Virginia, and an MS in Finance and a Master of Decision Analytics (MDA) degree from Virginia Commonwealth University, where he was a Dean’s Scholar.
Ali McBride, PharmD, MS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. He currently serves as President-Elect of the Association of Community Cancer Centers (ACCC). In addition to being a long-time ACCC member, and Dr. McBride has been actively involved with the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA).
Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at the U.S. Food and Drug Administration (FDA) Drug Shortage Workshop; presented on behalf of ACCC at the Washington, D.C., Congressional Session; and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacoeconomic impact of biosimilars into the U.S. marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. healthcare market.
Randall A. Oyer, MD, is medical director of the oncology program at Lancaster General Health, a community health system in Lancaster, Pennsylvania. Dr. Oyer divides his time among patient care, program administration, program development, and community outreach. He works closely with a multidisciplinary team comprising nursing, social work, pharmacy, chaplaincy and medical specialties focused on strategy, implementation, and patient care. Lancaster General opened the Ann B. Barshinger Cancer Institute in July 2013 using an integrated care model and working closely with its academic partner, the Abramson Cancer Center of the University of Pennsylvania.
Dr. Oyer is an active member of ACCC, attending national and regional meetings, serving on the Governmental Affairs Committee, participating in Capitol Hill visits, and serving as co-chair of the Advisory Committee for the ACCC Optimal Care Coordination Model for Lung Cancer Patients on Medicaid initiative. In addition, he has served as a member of the CMS Ambulatory Payment Classification Panel and ASCO’s Clinical Practice Committee.
Dr. Oyer is a graduate of Georgetown University and Georgetown University School of Medicine.
Krista Nelson, MSW, LCSW, OSW-C, BCD, is trained as an oncology social worker and works in clinical, research, and program management roles within Providence Health and Services. Ms. Nelson recently joined the Compassion team as a Program Manager, and she appreciates the opportunity to bring her clinical expertise to work on creating supportive infusions of compassion to caregivers.
She provides individual support as well as group support for those affected with cancer. She facilitates a Young Survival Coalition (YSC) online support group for women with metastatic cancer and runs a program for children with a parent with cancer. In 2015 Providence Cancer Center received an ACCC Innovator Award for its Family Program for Parents with Cancer and Their Children.
Ms. Nelson defines her role as providing support for people and their families throughout the cancer continuum and sharing the expertise that she has learned from other patients with cancer. In working with those affected by cancer, she loves, “being able to witness the grace, courage, and life lessons of individuals dealing with cancer and the opportunity to be a part of their journey.”
She is a Past President of the Board of Directors of the Association of Oncology Social Work (AOSW) and past Invited Director of the American Psychosocial Oncology Society (APOS). She loves being a part of the national discussion involving the psychosocial care of people with cancer.
She has been a speaker at local and national conferences on issues of survivorship, palliative care, distress screening, and children who have a parent with cancer. Krista also serves as an Invited Director on the board of directors of the National Accreditation Program for Breast Centers (NAPBC), and as a Director of the American Clinical Social Work Association (ACSWA). In 2015, Krista was named as a finalist in the Schwartz Center Compassionate Caregiver of the Year Award.
Krista also has been a volunteer facilitator at retreats for women with breast cancer and at camps and programs that support grieving children. She also has volunteered annually on medical relief teams to Haiti since 2009.
Mark S. Soberman, MD, MBA, FACS, is medical director, Oncology Service Line and chief physician executive, Monocacy Health Partners, and a member of the Board of Managers of the Frederick Integrated Healthcare Network at Frederick Regional Health System in Frederick, Maryland. He is a reviewer for the Annals of Thoracic Surgery and a member of the Society of Thoracic Surgeons, Southern Thoracic Surgical Association, General Thoracic Surgical Club, American Association for Physician Leadership, American College of Healthcare Executives, and the American Society of Clinical Oncology.
Previously, he served as vice-chair of the Department of Surgery; director, Section of Thoracic Oncology; and director, Section of Thoracic Surgery, at the Washington Hospital Center. He has also held the positions of director, Division of Thoracic Surgery at Georgetown University Hospital and director, Section of Thoracic Surgery at Sibley Memorial Hospital. His academic appointments include Clinical Associate Professor of Surgery at Georgetown University School of Medicine and Clinical Assistant Professor of Surgery at George Washington University School of Medicine.
Dr. Soberman earned his undergraduate degree in Biology at Washington University in St. Louis with Eliot Honors, and graduated from the Emory University School of Medicine. After completing a residency in General Surgery at Emory University Affiliated Hospitals, he went on to complete his residency Cardiothoracic Surgery at George Washington University and an advanced fellowship in General Thoracic Surgery at the Cleveland Clinic.
Dr. Soberman has been the recipient of two Alley-Sheridan Fellowships from the Thoracic Surgery Foundation for Research and Education, completing executive courses in Health Policy at Harvard’s John F. Kennedy School of Government. In 2009, he completed an MBA at the Darden School of Business, University of Virginia, receiving a faculty award for academic excellence. In 2014, he attended Professor Michael Porter’s Intensive Value-Based Health Care Delivery Symposium at Harvard Business School.
Dr. Soberman has lectured extensively, both nationally and internationally on topics relating to thoracic oncology and more recently, value-based health care delivery. His professional interests include the study value-based healthcare, innovative care delivery models and innovative payment models, value in oncology, and multidisciplinary cancer care models.
Olalekan “Lekan” Ajayi, PharmD, MBA, is oncology service line manager at Sheridan Memorial Hospital in Sheridan, Wyoming. In this role, Dr. Ajayi oversees both strategic and operational initiatives of the oncology and internal medicine programs. He has also worked extensively as a clinical pharmacist and an oncology pharmacy manager for eight years.
Dr. Ajayi currently serves on the ACCC Board of Trustees and has worked on a number of ACCC initiatives.
He is passionate about patient access to quality cancer care in rural communities. Specifically, Dr. Ajayi is interested in expanding patient access to oncology clinical trials and is working with ACCC on ways to overcome the challenges of patient accruals for clinical trials in rural cancer programs.
He holds a Doctor of Pharmacy degree from the University of Wyoming, and a Master’s in Business Administration from the University of Colorado, Denver.
Dr. Nadine J. Barrett is a medical sociologist and an assistant professor in the Department of Community and Family Medicine, within Duke University’s School of Medicine. She is the inaugural director of the Office of Health Equity and Disparities at the Duke Cancer Institute and serves as the director of the Duke Community Engagement Core, within the Center for Community and Population Health Improvement. A health equity and stakeholder engagement strategist, Dr. Barrett applies her expertise across three interrelated areas: 1) linking vulnerable communities to health services and research, 2) leveraging community and health system assets and services to align priorities and improve community and population health, and 3) convening diverse stakeholders to develop community and patient-centered programs, services, and research.
In 2017, she accepted an ACCC Innovator Award on behalf of Duke Cancer Institute for its initiative, Come Together: A Health Disparities & Equity Cancer Program Built on Community Collaboration. She is the recipient of several awards, including the American Sociology Association’s Minority Fellowship Award, an NIH Postdoctoral Fellowship in Health Services Research, and the MLK Southern Christian Leadership Conference Drum Major for Justice Award. Her national appointments include the PCORI Health Disparities Advisory Panel Board and the ACCC Board of Trustees. Dr. Barrett is both passionate about and committed to achieving health equity.
Dr. Barrett has several funded projects including Project PLACE (Population Level Approaches to Cancer Elimination), funded by the National Cancer Institute (NCI), which is a three-pronged research project designed to implement three robust mechanisms to inform the health equity strategic direction of the Duke Cancer Institute over the next five to eight years. Project PLACE is a highly intensive community engagement model and platform designed to shape robust scholarly productivity, partnered research and community programs to improve population health. She is also the Duke PI (subcontract) of a national Susan G. Komen pipeline training grant on translational research in inflammatory breast cancer and community-engaged research. Dr. Barrett also co-directs the NCI-funded Cancer Research and Education Program Core of the NCCU/DCI Translational Health Disparities Research Program which incorporates specified training in minority accrual in clinical research—a program she developed within the Duke Cancer Institute titled, “Just Ask.”
Catherine Brady-Copertino, BSN, MS, OCN, serves as the executive director of the Geaton and JoAnn DeCesaris Cancer Institute (DCI) at Anne Arundel Medical Center in Annapolis, Maryland. In this role, Catherine provides strategic and operational leadership for the Institute, a Commission on Cancer-approved cancer program that diagnoses more than 1,800 new cancer cases annually and treats more than 300 ambulatory patients each day, making the DCI one of the largest cancer programs in Maryland.
Catherine has presented and published nationally and has served on numerous committees and boards including Governor-appointed membership on the State of Maryland’s Council on Cancer Control, the Maryland Cancer Plan’s Breast Committee, as chair of the Anne Arundel County Health Department’s Conquer Cancer Task Force, John Hopkins Network Clinical Research Steering Committee, Susan G. Komen Grant Review Board, Hospice of the Chesapeake Board of Directors, and the Oncology Nursing Society’s Capitol Gang as a health policy patient and nurse advocate. In addition, she is one of the two founding directors in Global Oncology Services Ireland, Ltd., an oncology medical service provider in Ireland since 2006. Global Oncology provides oncology program development and professional services to the private sector hospitals in Galway and Dublin.
She received her BS degree in Nursing from the Catholic University of America, Washington, D.C., and her MS in Health Care Administration from the University of Maryland. She has been an Oncology Certified Nurse (OCN) for more than 35 years.
Melanie Feinberg is Director, Oncology Quality, Maine Medical Center/MaineHealth. In this role, for the past 15 years she has overseen the quality program for both Maine Medical Center and MaineHealth Oncology. Ms. Feinberg has extensive experience in developing systems to measure and benchmark quality. The successful completion of the MaineHealth multi-hospital tumor registry network ensures that there will be a single source for clinical outcomes information to inform development of a regional oncology care delivery model.
She is President-Elect of the Cancer Registrars Association of Maine and a member of the ACCC Education Committee. In addition Ms. Feinberg serves as Chair of the Maine Cancer Foundation’s Treatment Work Group and is a board member of Hospice of Southern Maine (HSM), as well as a working member of HSM’s Quality of Care Committee.
Amanda A. Henson, MSHA, MBA, FACHE, is Vice President of Oncology at Baptist Health Lexington, a community-based hospital located in Lexington, Kentucky. Baptist Health Lexington is part of Baptist Health; a health system comprised of nine hospitals throughout Kentucky and Southern Indiana, and headquartered in Louisville, Kentucky. As Vice President, Ms. Henson is responsible for the administrative oversight, financial management, and overall program development for the cancer service line. In addition, Ms. Henson has administrative responsibilities for several other departments at Baptist Health Lexington, including the hospital foundation office, environmental services, laundry, materials management, clinical research and community education.
Ms. Henson leads system-wide initiatives including Executive Sponsor of the Cancer Service Line Council and Co-Sponsor of the Research Resource Council for Baptist Health System. Ms. Henson helped lead the integration of federally funded oncology research collaboration for all Baptist hospitals under the Baptist Health Cancer Research Network. In addition, Ms. Henson has been involved in the development of Baptist Health’s first system service line council. This council is instrumental in standardization of oncology care, dashboard quality metrics, and strategic planning.
Throughout her career in oncology management, both in an academic medical center and community cancer centers, Ms. Henson has successfully led programs through accreditation surveys with the Commission on Cancer (CoC), as well as the National Accreditation Program for Breast Centers (NAPBC). She has extensive experience implementing oncology EMR systems. Additionally, during her previous role as Administrative Director of Cancer Services at DCH Regional Medical Center in Tuscaloosa, Alabama, Ms. Henson was responsible for overseeing the construction of a 90,000-square-foot cancer center.
Ms. Henson previously served on the Association of Community Cancer Centers (ACCC) Editorial Committee and Nominating Committee. She is Past President of the University of Alabama at Birmingham’s Graduate Program in Healthcare Administration Alumni Board. Currently she serves as a preceptor for healthcare management students from the University of Kentucky and is actively engaged in community programs and civic organizations, including serving on the board for Court Appointed Special Advocates (CASA) of Lexington.
Ms. Henson received her undergraduate degree from Centre College, in Danville, Kentucky. She also received her MBA and MSHA degrees from the University of Alabama at Birmingham. Ms. Henson is a Fellow within the American College of Healthcare Executives and is the 2015 recipient of the Early Career Healthcare Executive Regent’s Award from the Kentucky Chapter of American College of Healthcare Executives (ACHE).
Una Hopkins, RN, FNP-BC, DNP, is a registered nurse with more than 30 years of experience in oncology, 25 as a nurse practitioner. Before coming to White Plains Hospital, Dr. Hopkins worked as an Oncology Nurse Practitioner and Clinical Trials Coordinator at Montefiore Medical Center’s Albert Einstein Cancer Center in the Bronx. She is currently an adjunct professor at NYU School of Nursing. Dr. Hopkins has received numerous awards for her accomplishments in clinical and research work and since 1927, has published over 20 articles in various medical journals. She holds bachelor’s and master’s degrees in Nursing Science from the College of New Rochelle where she also studied to become a family nurse practitioner. She received her doctorate from Pace University in New York City. Dr. Hopkins serves on the Advisory Committee for the ACCC Institute for Clinical Immuno-Oncology.
Barbara Jensen, RN, BSN, MBA, is a dynamic nurse leader and the Director of Oncology, Diagnostic Imaging and Palliative Care at Skagit Regional Health in Mount Vernon, Washington. Ms. Jensen has over 22 years of healthcare experience in a variety of settings to include oncology, home health, home infusion, orthopedic and surgical care, and wound care. As an ad hoc teaching faculty member for the Skagit Valley Community College Nursing Program, Ms. Jensen teaches “Oncology 101” as an introduction to oncology for second year students, laying the foundation for oncology patient nursing management. A long-time ACCC member, Ms. Jensen currently serves on the ACCC Guidelines Committee.
During her tenure as Director of Oncology she has led her team through successful accreditation surveys for the cancer center to include the Commission on Cancer (CoC) with Commendation, National Accreditation Program for Breast Centers (NAPBC), and the Quality Oncology Practice Initiative (QOPI) certification program. Since 2010 she has worked with the multidisciplinary team of The Breast Institute to improve breast cancer screening volumes and technology in the Skagit Valley, and will see this come to fruition in a new women’s imaging center set to open early 2019 that will bring 3-D mammography to the region.
With a heart for philanthropy, Ms. Jensen is a past member of the Hospice of the Northwest Board of Trustees helping to raising both awareness and funds for the local hospice program. Currently she is serving on the Board of Directors of the Skagit Valley Hospital Foundation supporting their mission to raise funds that will ensure the continued availability of quality health care services for the patients in Skagit Valley.
Ms. Jensen obtained her BSN degree at Seattle Pacific University and an MBA with a focus on healthcare from Western Governors University.
Laeton Pang, MD, MPH, FACR, FACRO, is a radiation oncologist with Pacific Radiation Oncology, LLC. A leader in Hawaii’s oncology professional community, Dr. Pang is a founding member of the Hawaii Society of Clinical Oncology (HSCO), a clinical instructor for the John A. Burns School of Medicine, and serves as the radiation oncology representative to the Hawaii Medicare Carrier Advisory Committee (CAC).
Dr. Pang has served as President for the Hawaii Society of Clinical Oncology, Board Member for the American Cancer Society, Medical Director for Leeward Radiation Oncology and Vice-Chairman of the Cancer Institute. Dr. Pang believes that his job is his calling and he lives and breathes advocacy for cancer patients and improvement of cancer care for Hawaii and the world.
He is a graduate of Iolani School, University of Hawaii-Manoa, Tulane University Schools of Medicine and Public Health, and completed his residency at the University of Virginia Health Sciences Center.
Kashyap Patel, MD, Managing Partner, Carolina Blood & Cancer Care Associates, is a board certified hematologist/oncologist who specializes in palliative care. He is a full-time practicing medical oncologist with 20 years of experience working directly with cancer patients.
Dr. Patel is a past president of the South Carolina Oncology Society. He serves on the board of the Community Oncology Alliance (COA), on the advisory board for Medicaid HMOs, and has been a Carrier Advisory Committee (CAC) member for the DHHS (SC), Palmetto GBA. Dr. Patel has a special interest in healthcare policy and economics and new alternative payment models.
Dr. Patel completed his residency at Jamaica Hospital in New York City and a fellowship in Hematology and Medical Oncology at Thomas Jefferson University Hospital in Philadelphia. He is a certified trainer for physicians on “Education in Palliative and End of Life Care,” and has published journal articles and presented both nationally and internationally.
David R. Penberthy, MD, MBA, is President of Virginia Radiation Oncology Associates, Inc. a private medical practice based in Richmond, Virginia where he has practiced since completing residency at the University of Virginia in 2002. After completing his MBA from the Darden School of Business at the University of Virginia in 2011, Dr. Penberthy has served as the Medical Director of Radiation Oncology and Cancer Committee Chairman at Southside Regional Medical Center in Petersburg, Virginia. During his tenure as chairman, Dr. Penberthy led SRMC’s oncology program through two American College of Surgeons Commission on Cancer accreditation surveys resulting in cancer program accreditation, each time earning an Outstanding Achievement Award, an accolade achieved by only a small fraction of community oncology programs in the country.
After earning a Bachelor of Science degree in Electrical Engineering from Virginia Tech and a Doctor of Medicine degree from Virginia Commonwealth University, Dr. Penberthy completed a surgical internship at Bethesda Naval Hospital. He then served as a US Navy Flight Surgeon with Fighter Squadron 101 in Oceana, Virginia. His strong interest and knowledge of technology eventually led him to the field of Radiation Oncology. In this field, Dr. Penberthy applies sophisticated medical technologies to alleviate the suffering caused by cancer, one of the most pressing medical issues of our generation.
Dr. Penberthy is enthusiastic about patient care and he is intensely engaged in providing state of the art, patient centered, compassionate oncology care.